Report error Found 4 Enz. Inhib. hit(s) with all data for entry = 13304
TargetSalicyl-AMP ligase / salicyl-S-ArCP synthetase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Affinity DataKi: 26.6nMAssay Description:For each compound, the progress curves displayed a nonlinear profile of H10MbtAopt inhibition with the characteristic three phases of a time-dependen...More data for this Ligand-Target Pair
Ligand Info
TargetSalicyl-AMP ligase / salicyl-S-ArCP synthetase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Affinity DataKi: 158nMAssay Description:For each compound, the progress curves displayed a nonlinear profile of H10MbtAopt inhibition with the characteristic three phases of a time-dependen...More data for this Ligand-Target Pair
Ligand Info
TargetSalicyl-AMP ligase / salicyl-S-ArCP synthetase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Affinity DataKi: 277nMAssay Description:For each compound, the progress curves displayed a nonlinear profile of H10MbtAopt inhibition with the characteristic three phases of a time-dependen...More data for this Ligand-Target Pair
Ligand Info
TargetSalicyl-AMP ligase / salicyl-S-ArCP synthetase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Memorial Sloan-Kettering Cancer Center; Research Foundation of the City University of New York; The Johns Hopkins University
US Patent
Affinity DataKi: 295nMAssay Description:For each compound, the progress curves displayed a nonlinear profile of H10MbtAopt inhibition with the characteristic three phases of a time-dependen...More data for this Ligand-Target Pair
Ligand Info
